http://newsroom.martek.com/ Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of DHA Omega-3 products that promote health and wellness through every stage of life. The Company produces life'sDHA™, a vegetarian source of the omega-3 fat http://newsroom.martek.com/index.php?s=press_releases&item=312 Third Quarter Highlights: - Revenues of $88.4 million, up 14% from the prior year's third quarter - Earnings per share of $0.28, an increase of 47% over last year's third quarter - Operating cash flow of $23 million (Year-to-date operating cash flow of $6 Thu, 4 Sep 2008 16:05:00 -0400 http://newsroom.martek.com/index.php?s=press_releases&item=312 http://newsroom.martek.com/index.php?s=press_releases&item=311 Thu, 4 Sep 2008 09:00:00 -0400 http://newsroom.martek.com/index.php?s=press_releases&item=311 http://newsroom.martek.com/index.php?s=press_releases&item=310 Thu, 21 Aug 2008 13:00:00 -0400 http://newsroom.martek.com/index.php?s=press_releases&item=310 http://newsroom.martek.com/index.php?s=press_releases&item=309 In the news release, Martek to Announce Second Quarter 2008 Results on September 4, 2008, issued earlier today by Martek Biosciences Corporation (Nasdaq: MATK) over PR Newswire, we are advised by the company that the headline should read "Third Quarter" r Thu, 21 Aug 2008 12:46:00 -0400 http://newsroom.martek.com/index.php?s=press_releases&item=309 http://newsroom.martek.com/index.php?s=press_releases&item=308 Thu, 21 Aug 2008 12:00:00 -0400 http://newsroom.martek.com/index.php?s=press_releases&item=308